This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Wet age-related macular degeneration, under 50
WET_AMD_EARLY
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersPre-conditions: EVENT_AGE<50 Registry filters:
2 out of 7 registries used, show all original rules. |
141 |
4. Check minimum number of eventsNone |
141 |
5. Include endpointsNone |
141 |
6. Filter based on genotype QC (FinnGen only) |
115 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- H35
- Name in latin
- Degeneratio maculae senilis exsudativa
Similar endpoints
↥List of similar endpoints to
Wet age-related macular degeneration, under 50
based on the number of shared cases.
Similar with more cases:
- Degeneration of macula and posterior pole
- Other retinal disorders
- Disorders of choroid and retina
- Diseases of the eye and adnexa
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 115 | 59 | 56 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 42.21 | 41.12 | 43.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 123
- Matched controls
- 1230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
12476.5
166.2
121
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
124.0
117.9
62
10
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
29.0
76.5
63
43
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
40.8
75.8
51
21
XCK10
NOMESCO Finland
Photography of fundus of eye
28.7
75.5
62
42
XCW99
NOMESCO Finland
Other investigative procedure of eye
23.5
67.9
62
51
CKC12
NOMESCO Finland
Photocoagulation of retina
25.5
50.3
39
22
Z01.0
ICD-10 Finland
Examination of eyes and vision
12.3
44.5
65
103
XCD20
NOMESCO Finland
Photoangiography of eye
77.5
34.7
38
7
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
100.4
34.0
36
5
A10AE05
ATC
insulin detemir; parenteral
13.7
28.0
29
27
A10AC01
ATC
insulin (human); parenteral
11.1
27.5
34
41
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
155.3
24.6
25
*
A10AB01
ATC
insulin (human); parenteral
11.8
24.5
28
30
A10AB05
ATC
insulin aspart; parenteral
9.9
24.2
32
42
Z96.1
ICD-10 Finland
Presence of intraocular lens
11.3
23.0
27
30
CKC10
NOMESCO Finland
Local photocoagulation of retina
54.2
22.4
26
6
A10AA01, ,
ATC
11.1
22.0
26
29
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
10.2
21.4
27
33
H36.01
ICD-10 Finland
Diabetic maculopathy
44.2
20.8
25
7
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
7.4
20.6
36
65
T89
ICPC
Diabetes insulin dependent
10.0
20.4
26
32
XCH00
NOMESCO Finland
Eye pressure measurement
26.1
19.7
27
13
H43.1
ICD-10 Finland
Vitreous haemorrhage
66.3
19.7
22
*
H3603, E103,
ICD-10 Finland
74.1
17.3
19
*
H35.7
ICD-10 Finland
Separation of retinal layers
33.0
17.2
22
8
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
195.4
16.9
17
*
ZXA10
NOMESCO Finland
Bilateral
5.6
16.8
41
101
A10AE04
ATC
insulin glargine; parenteral
6.9
16.1
29
53
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
19.9
15.5
23
14
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
12.4
14.3
26
26
CK9G4
NOMESCO Finland
Iridocyanine green angiography (ICGA) of choroid and retina
+∞
13.8
13
*
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
+∞
13.8
13
*
103
Kela drug reimbursment
Diabetes, insulin-treated
4.3
13.5
49
163
H25.1
ICD-10 Finland
Senile nuclear cataract
6.4
13.4
25
47
A10AA02, ,
ATC
10.9
13.0
25
28
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
11.6
13.0
24
25
H36.00
ICD-10 Finland
Diabetic background retinopathy
36.4
12.9
16
5
215
Kela drug reimbursment
Diabetes, non-insulin-treated
4.1
12.2
47
162
TCK00
NOMESCO Finland
Photosensitisation of choroid and retina
+∞
11.6
11
*
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
39.1
11.5
14
*
H35.9
ICD-10 Finland
Retinal disorder, unspecified
48.0
11.2
13
*
H3601, E103,
ICD-10 Finland
24.1
11.0
15
7
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
65.9
10.8
12
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
26.1
10.5
14
6
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.7
10.3
45
167
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
44.0
10.2
12
*
A11CC03
ATC
alfacalcidol; systemic
44.0
10.2
12
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
28.8
10.0
13
5
A10AB04
ATC
insulin lispro; parenteral
9.7
10.0
20
24
S01ED51
ATC
timolol, combinations; ophthalmic
9.7
10.0
20
24
ZXA05
NOMESCO Finland
Left side
3.8
9.9
40
140
H04AA01
ATC
glucagon; nasal, parenteral
11.5
9.9
18
18
Z49.0
ICD-10 Finland
Preparatory care for dialysis
59.8
9.8
11
*
A10AE06
ATC
insulin degludec; parenteral
9.3
9.8
20
25
S01EC01
ATC
acetazolamide; systemic
19.5
9.7
14
8
XCD10
NOMESCO Finland
Electrophysiological examination of eye
24.0
9.6
13
6
B05DB
ATC
Hypertonic solutions
108.0
9.6
10
*
H3601, E106,
ICD-10 Finland
108.0
9.6
10
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
12.9
9.4
16
14
H3600, E103,
ICD-10 Finland
17.3
9.3
14
9
WX100
NOMESCO Finland
Conjunctival surface anesthesia
9.1
9.3
19
24
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
26.3
9.1
12
5
H26.4
ICD-10 Finland
After-cataract
10.2
8.9
17
19
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
53.9
8.8
10
*
Z3229
NOMESCO Finland
Other healthcare associate professional
5.3
8.7
19
41
Z94.0
ICD-10 Finland
Kidney transplant status
29.9
8.6
11
*
C03CA01
ATC
furosemide; systemic
3.9
8.4
29
90
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
18.8
8.3
12
7
B05DA
ATC
Isotonic solutions
36.0
8.2
10
*
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
48.1
7.8
9
*
127
Kela drug reimbursment
Transplant complication
19.9
7.8
11
6
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
26.9
7.7
10
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
26.9
7.7
10
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
26.9
7.7
10
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
26.9
7.7
10
*
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
14.6
7.6
12
9
H3603, E106,
ICD-10 Finland
85.0
7.5
8
*
CA1ME
NOMESCO Finland
Ultrasound oculometry
85.0
7.5
8
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
85.0
7.5
8
*
H35.6
ICD-10 Finland
Retinal haemorrhage
85.0
7.5
8
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
85.0
7.5
8
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
8.2
7.5
16
22
H3603, E113,
ICD-10 Finland
+∞
7.4
7
*
205
Kela drug reimbursment
Chronic hypertension
3.8
7.4
26
82
L04AA06
ATC
mycophenolic acid; systemic
14.9
7.0
11
8
Z49.2
ICD-10 Finland
Other dialysis
42.5
6.8
8
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
42.5
6.8
8
*
B03XA02
ATC
darbepoetin alfa; parenteral
24.1
6.8
9
*
137
Kela drug reimbursment
Uraemia requiring dialysis
24.1
6.8
9
*
C09AA02
ATC
enalapril; systemic
3.9
6.6
21
61
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
15.4
6.5
10
7
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
73.5
6.5
7
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
19.2
6.4
9
5
TK800
NOMESCO Finland
Hemodialysis
19.2
6.4
9
5
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
+∞
6.3
6
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
+∞
6.3
6
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.4
6.2
12
14
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
9.4
6.2
12
14
S01BC03
ATC
diclofenac; ophthalmic
13.5
6.2
10
8
Z3231
NOMESCO Finland
Registered nurse
2.7
6.1
43
203
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.0
6.1
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
281
2.92
7.74
10.9
4.2
39.97
8.96
mg/mmol
0.80
47
192
32
115
3.41
7.45
22.2
6.5
1.13
1.02
mmol/l
1.39
32
105
6
0
+∞
6.30
5.7
0.0
512.67
—
umol/l
—
6
0
64
383
2.40
5.37
2.0
1.8
91.56
98.38
pmol/l
0.42
32
203
25
95
3.05
5.21
1.6
1.5
1193.80
1203.79
nmol/l
0.02
20
76
16
48
3.68
4.79
8.6
8.0
20.50
24.86
mmol/l
1.66
16
48
12
26
5.00
4.18
3.2
1.9
3.23
3.66
g/l
0.40
12
26
10
19
5.63
3.92
1.6
1.5
—
—
—
0
0
22
92
2.69
3.82
14.1
14.5
4.95
5.16
kpa
0.50
22
85
19
74
2.85
3.76
2.8
2.4
67.38
75.11
ml/min/173m2
—
8
36
10
21
5.08
3.64
2.6
2.1
—
—
—
0
0
19
76
2.77
3.58
15.1
16.9
111.63
126.47
g/l
1.52
19
70
17
66
2.83
3.38
6.1
2.2
5.08
4.40
kpa
1.05
17
66
22
98
2.52
3.37
1.5
2.1
407.05
369.78
nmol/l
0.52
22
93
13
43
3.26
3.36
10.6
1.7
22.08
24.94
mmol/l
2.30
13
43
47
291
2.00
3.24
1.4
1.3
4.97
1.15
u/ml
0.45
16
82
13
44
3.19
3.24
15.3
21.8
14.36
16.94
%
1.94
13
38
11
30
3.92
3.18
2.8
1.4
—
—
—
0
0
13
45
3.11
3.13
3.5
2.1
0.57
0.65
%
0.35
13
45
10
29
3.66
2.76
3.0
1.3
106.60
92.69
%
—
10
29
13
51
2.73
2.54
16.5
12.5
0.72
0.65
%
0.22
13
51
24
129
2.07
2.38
2.2
1.9
—
—
—
0
0
11
40
2.92
2.34
21.2
3.4
23.37
24.28
mmol/l
0.47
11
40
8
23
3.64
2.31
3.8
1.8
156.25
160.17
%
—
8
23
59
428
1.73
2.30
28.4
8.3
1.21
1.21
mmol/l
0.15
53
376
8
24
3.49
2.22
4.5
2.2
—
—
—
0
0
13
55
2.52
2.20
15.9
11.9
1.34
1.64
%
0.34
13
55
6
14
4.45
2.18
1.3
1.1
108.33
115.00
%
—
6
14
6
14
4.45
2.18
1.7
1.1
—
—
—
0
0
8
25
3.35
2.13
3.5
2.5
24.54
25.77
mmol/l
—
8
25
8
25
3.35
2.13
1.0
1.8
—
—
—
0
0
6
15
4.15
2.06
1.3
1.9
394.83
104.38
ug/l
—
6
15
13
57
2.43
2.06
16.5
11.6
94.96
93.26
%
0.62
13
57
8
26
3.22
2.05
1.1
1.1
—
—
—
0
0
9
32
2.95
2.04
1.8
1.8
—
—
—
0
0
47
330
1.69
2.00
2.7
2.8
24.78
21.43
ng/l
0.16
30
170
67
516
1.66
2.00
6.4
2.9
99.73
100.69
ug/l
0.03
67
495
7
22
3.31
1.91
4.3
1.8
—
—
—
0
0
6
17
3.65
1.86
1.3
1.1
—
—
—
0
0
24
141
1.87
1.85
5.3
2.4
0.41
0.79
e6/l
—
10
64
13
60
2.30
1.85
3.8
3.9
64.95
68.78
g/l
0.66
13
60
12
55
2.31
1.74
3.0
1.9
619.43
6961.27
u/l
—
5
21
5
13
3.96
1.73
12.0
1.6
8.74
5.08
pmol/l
—
5
13
33
219
1.69
1.70
2.3
1.7
1.15
0.68
mg/l
0.61
25
168
30
194
1.72
1.70
2.7
2.8
6422.21
520.46
ng/l
0.57
24
161
10
44
2.38
1.60
7.8
2.9
62.52
47.59
%
—
10
44
22
132
1.81
1.59
5.8
2.5
1.46
3.29
e6/l
—
8
55
5
16
3.21
1.45
3.4
1.9
—
—
—
0
0
7
29
2.50
1.41
1.0
1.6
—
—
—
0
0
14
75
1.98
1.41
2.0
3.0
—
—
—
0
0
19
114
1.79
1.38
16.5
8.1
104.68
104.53
mmol/l
0.05
19
114
11
54
2.14
1.37
1.8
1.9
370.00
305.78
mu/l
0.43
11
49
12
63
2.00
1.28
1.7
1.7
—
—
—
0
0
5
19
2.70
1.23
1.0
1.7
—
—
—
0
0
6
26
2.37
1.20
1.0
1.1
—
1.09
—
0
7
66
551
1.43
1.13
6.5
3.1
0.00
0.00
estimate
-0.00
12
100
32
233
1.50
1.11
3.7
2.1
—
—
—
0
0
16
98
1.73
1.10
1.5
1.7
—
—
—
0
0
73
624
1.42
1.08
13.5
11.2
4.55
3.97
e9/l
1.11
66
550
9
47
1.99
1.05
1.7
3.4
18.72
37.13
u/ml
—
9
47
7
34
2.12
1.04
1.1
1.6
0.21
0.25
g/l
—
7
34
5
22
2.32
1.04
1.6
1.6
75.40
54.57
pmol/l
—
5
22
5
22
2.32
1.04
1.2
2.2
—
—
—
0
0
11
61
1.88
1.02
1.6
1.8
—
—
—
0
0
7
35
2.06
1.02
1.1
1.6
1.13
1.22
g/l
—
7
35
78
873
0.71
1.00
3.3
3.7
—
—
—
0
0
64
541
1.38
0.97
6.6
3.1
0.00
0.00
estimate
-0.00
12
99
65
552
1.38
0.96
6.6
3.2
0.00
0.00
estimate
-0.00
12
94
6
29
2.12
0.90
6.2
3.0
2.33
2.79
g/l
—
6
29
31
234
1.43
0.90
9.7
2.7
0.21
0.31
e6/l
0.36
25
161
6
30
2.05
0.88
6.2
3.0
4.37
4.27
g/l
—
6
30
6
30
2.05
0.88
6.2
3.0
4.00
3.82
g/l
—
6
30
6
30
2.05
0.88
6.2
3.0
7.65
6.71
g/l
—
6
30
24
173
1.48
0.87
5.1
3.0
23.47
170.17
ng/l
1.17
17
102
8
45
1.83
0.86
1.5
1.2
—
—
—
0
0
16
106
1.59
0.84
1.5
1.7
—
—
—
0
0
6
32
1.92
0.83
1.2
1.8
—
—
—
0
0
21
285
0.68
0.81
1.4
1.7
—
—
—
0
0
12
74
1.69
0.81
1.0
1.3
132.90
697.85
u/ml
0.81
12
65
0
26
0.00
0.79
0.0
1.3
—
1.28
—
0
5
6
34
1.80
0.77
1.3
2.0
—
—
—
0
0
5
23
2.22
0.77
1.0
1.7
—
—
—
0
0
5
24
2.13
0.75
2.4
2.3
—
—
—
0
0
5
25
2.04
0.73
7.2
2.9
6.86
11.82
g/l
—
5
25
55
470
1.31
0.72
3.3
2.7
—
—
estimate
—
0
0
40
329
1.32
0.69
5.5
2.4
0.00
0.00
estimate
-0.00
11
79
118
1202
0.55
0.67
38.5
19.5
40.14
41.78
%
2.49
118
1194
118
1202
0.55
0.67
37.1
19.2
135.48
139.97
g/l
2.30
118
1194
118
1202
0.55
0.67
36.9
19.1
4.55
4.65
e12/l
1.16
118
1186
118
1202
0.55
0.67
36.7
19.1
89.79
90.32
fl
0.65
118
1195
7
44
1.63
0.66
1.0
1.1
—
—
—
0
0
5
29
1.75
0.64
1.6
1.8
9.66
1.04
ug/l
—
5
29
110
1046
1.49
0.62
23.9
11.1
85.11
91.09
ml/min/173m2
1.79
105
957
118
1200
0.59
0.62
36.9
19.2
261.57
257.10
e9/l
0.29
118
1187
91
842
1.31
0.61
5.0
4.3
14.52
14.58
pmol/l
0.09
84
806
101
949
1.36
0.60
27.7
15.5
13.62
13.34
%
1.55
101
942
9
60
1.54
0.56
1.8
1.3
—
—
—
0
0
48
415
1.26
0.55
5.5
2.8
0.00
0.00
estimate
-0.00
12
81
6
39
1.57
0.54
1.0
1.1
—
2.91
—
0
11
112
1077
1.45
0.49
26.3
12.6
22.39
19.57
mg/l
0.41
91
853
115
1113
1.51
0.48
7.3
5.0
2.70
2.91
mmol/l
1.96
110
1074
106
1012
1.34
0.48
6.0
5.0
1.75
1.77
mu/l
0.09
99
968
31
261
1.25
0.44
6.5
3.4
0.00
0.00
estimate
—
10
97
55
494
1.21
0.42
2.3
1.9
1.38
1.45
mmol/l
0.30
47
435
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
9
67
1.37
0.39
1.1
1.0
—
—
—
0
0
16
200
0.77
0.38
2.3
2.2
—
—
—
0
0
118
1150
1.64
0.36
30.5
14.6
96.02
73.72
umol/l
1.75
118
1139
35
306
1.20
0.35
11.5
3.0
—
—
—
0
0
107
1033
1.28
0.34
6.6
4.2
6.92
5.79
mmol/l
3.38
102
980
37
333
1.16
0.26
12.0
2.8
53.59
66.58
u/l
0.47
37
308
9
76
1.20
0.25
1.3
1.4
—
262.82
—
0
39
5
37
1.37
0.24
1.2
1.6
—
—
—
0
0
8
101
0.78
0.22
3.0
2.1
—
—
—
0
0
19
218
0.85
0.21
2.3
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
222.42
—
0
10
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
77
0.77
0.16
1.8
3.2
4.27
4.69
pmol/l
—
6
65
16
179
0.88
0.13
1.8
1.5
—
—
—
0
0
21
228
0.90
0.11
1.5
3.6
25.86
22.89
%
—
5
74
8
75
1.07
0.07
1.0
1.4
—
—
—
0
0
8
93
0.85
0.07
4.1
5.8
—
—
—
0
0
24
227
1.07
0.06
1.5
1.3
19.00
21.53
iu/ml
—
6
68
12
110
1.10
0.05
3.3
2.3
—
—
—
0
0
18
190
0.94
0.04
1.2
2.3
1.02
0.75
ug/l
—
6
83
105
1056
0.96
0.00
6.1
4.0
1.31
1.34
mmol/l
0.16
99
1009
21
207
1.02
0.00
1.4
1.3
1.07
5.22
u/ml
—
7
91
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
46.00
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.6
—
7.26
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
25.77
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: WET_AMD_EARLY – Wet age-related macular degeneration, under 50
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).